Next Article in Journal
Quantifying Susceptibility of CD4+ Stem Memory T-Cells to Infection by Laboratory Adapted and Clinical HIV-1 Strains
Previous Article in Journal
Intracellular Trafficking of the Human Cytomegalovirus-Encoded 7-trans-Membrane Protein Homologs pUS27 and pUL78 during Viral Infection: A Comparative Analysis
Article Menu

Export Article

Open AccessReview
Viruses 2014, 6(2), 683-708; doi:10.3390/v6020683

Targeting Host Factors to Treat West Nile and Dengue Viral Infections

Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore 169857, Singapore
Center for RNA Biology, Duke University Medical Center, Durham, NC 27710, USA
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
Authors to whom correspondence should be addressed.
Received: 18 November 2013 / Revised: 3 February 2014 / Accepted: 4 February 2014 / Published: 10 February 2014
(This article belongs to the Section Antivirals & Vaccines)
View Full-Text   |   Download PDF [537 KB, uploaded 12 May 2015]


West Nile (WNV) and Dengue (DENV) viruses are major arboviral human pathogens belonging to the genus Flavivirus. At the current time, there are no approved prophylactics (e.g., vaccines) or specific therapeutics available to prevent or treat human infections by these pathogens. Due to their minimal genome, these viruses require many host molecules for their replication and this offers a therapeutic avenue wherein host factors can be exploited as treatment targets. Since several host factors appear to be shared by many flaviviruses the strategy may result in pan-flaviviral inhibitors and may also attenuate the rapid emergence of drug resistant mutant viruses. The scope of this strategy is greatly enhanced by the recent en masse identification of host factors impacting on WNV and DENV infection. Excellent proof-of-principle experimental demonstrations for host-targeted control of infection and infection-induced pathogenesis have been reported for both WNV and DENV. These include exploiting not only those host factors supporting infection, but also targeting host processes contributing to pathogenesis and innate immune responses. While these early studies validated the host-targeting approach, extensive future investigations spanning a range of aspects are needed for a successful deployment in humans. View Full-Text
Keywords: West Nile virus; dengue virus; host factor; drug targets West Nile virus; dengue virus; host factor; drug targets
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Krishnan, M.N.; Garcia-Blanco, M.A. Targeting Host Factors to Treat West Nile and Dengue Viral Infections. Viruses 2014, 6, 683-708.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top